Neomy Dialysis Center Brooklyn, NY - 11230

Neomy Dialysis Center is categorized under Kidney Dialysis Centers in Brooklyn, NY and active since 2009.

Neomy Dialysis Center was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214920 by the NAICS.

If you are seeking more information, feel free to contact Jack Meisels, Owner at the company’s single location by writing to 1122 Coney Island Avenue, Brooklyn, New York NY 11230 or by phoning (718) 434-1444. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Neomy Dialysis Center
Contact Person: Jack Meisels, Owner
Address: 1122 Coney Island Avenue, Brooklyn, New York 11230
Phone Number: (718) 434-1444
Website Address: neomydialysis.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2009
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Kidney Dialysis Centers
SIC Code: 8092
NAICS Code: 6214920
Share This Business:

Neomy Dialysis Center was started in 2009 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214920. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Jack Meisels, Owner for inquiries that concern Neomy Dialysis Center by calling the company number (718) 434-1444, as your correspondence is most welcome. Additionally, the physical location of the single location of Neomy Dialysis Center can be found at the coordinates 40.630201,-73.966274 as well as the street address 1122 Coney Island Avenue in Brooklyn, New York 11230.

For its online presence, you may visit Neomy Dialysis Center’s website at neomydialysis.com and engage with its social media outlets through on Twitter and on Facebook.